Rocaglaol Derivatives As Cardioprotectant Agents and As Antineoplastic Agents
The present invention discloses new rocaglaol derivatives and the use of rocaglaol derivatives to prevent or to limit the cardiotoxicity of an antineoplastic agent, in particular to prevent or to limit the apoptosis of cardiomyocytes induced by such agent.
DESAUBRY LAURENT [FR]; DESAUBRY GUNSEL CANAN [FR]; CRESTEIL THIERRY [FR]; TUERKERI GUELEN [FR]
Type of Offer:
« More Biotech Patents